Exclusion Criteria:~* Any medical or psychiatric contraindication or clinically significant abnormality that,
in the investigator's judgment, will substantially increase the risk associated with the subject's
participation in and completion of the study or could preclude the evaluation of the subject's response.~* Any
significant brain MRI abnormality.~* Use of any investigational drugs or devices, other than bapineuzumab
within the last 60 days prior to screening
